Tuesday, August 10, 2021
7:00 PM PT/10:00 PM ET

Biological Dynamics’ Kevin Han, CFO, will be joined by Dr. Dave Hoon, Professor and Director, Translational Molecular Medicine and Genome Sequencing at Saint John's Cancer Institute, to participate in a genomics fireside chat, Emerging Players in Liquid Biopsy, on Tuesday, August 10, at 7:00 PM PT. The session focuses on Biological Dynamics’ patented technology that empowers cancer detection at the earliest stages. In addition to a general liquid biopsy overview, the discussion covers an overview of Biological Dynamics’ proprietary platform that enables isolation of unique and differentiated biomarkers, such as exosomes, exo-proteins, surfaceomes, and extracellular vesicles.

Tuesday, August 10, 2021 at 7:00 PM, PT (webcast link)

The annual UBS Genomics 2.0 and MedTech Innovations Summit presents key opportunities and challenges facing the life sciences industry. Through networking, this exclusive invitation-only event will leverage the collective knowledge of attendees. The two-and-a-half-day intimate and informal program includes thought leadership via compelling fireside chats, expert panels, and keynote presentations alongside networking events and activities.

Topics to be addressed for genomics include liquid biopsy, synthetic biology, cancer screening, 3D spatial, regulatory/reimbursement, new technologies, data/informatics, consumer genomics, and government funding initiatives.